Regulatory dysfunction in leukotaxis.
- 1 September 1977
- journal article
- Vol. 88 (3) , 701-10
Abstract
The chemotactic factor inactivator (CFI) in human serum appears to have important regulatory function in the inflammatory response. In humans with elevated serum levels of CFI, defective mobilization of leukocytes in vivo has been noted, both in skin windows and in skin testing with various antigens. In experimental immune complex-induced acute inflammatory reactions in rat skin and lung, purified human CFI at very low doses has potent antiinflammatory effects and is able to suppress permeability changes, neutrophil infiltration, and hemorrhage, all of which are dependent initially on the role of leukotactic mediators.This publication has 14 references indexed in Scilit:
- Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.Journal of Clinical Investigation, 1977
- DEFECTIVE LEUKOTAXIS IN PATIENTS WITH LEPROMATOUS LEPROSY1976
- Antileukotactic properties of tumor cells.Journal of Clinical Investigation, 1975
- Defective regulation of chemotaxis in cirrhosis.1975
- Two Distinct Chemotactic Factor Inactivators in Human SerumThe Journal of Immunology, 1975
- Quantitative and qualitative studies of the local cellular exudative response in leprosy.1974
- Defective Regulation of Inflammatory Mediators in Hodgkin's DiseaseNew England Journal of Medicine, 1974
- Chemotactic Factor Inactivator in Normal Human SerumJournal of Clinical Investigation, 1973
- Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis.1972
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970